NASDAQ: LTRN
Lantern Pharma Inc Stock Ownership - Who owns Lantern Pharma?

Insider buying vs selling

Have Lantern Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
D. Jeffrey KeyserDirector2026-05-1248,544$2.06
$100.00kBuy
Lee Troy SchalopDirector2026-05-1248,544$2.06
$100.00kBuy

1 of 1

LTRN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LTRN insiders and whales buy or sell their stock.

LTRN Shareholders

What type of owners hold Lantern Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Leslie W. Kreis26.17%2,958,970$11.63MInsider
Aaron Gl Fletcher9.52%1,075,952$4.23MInsider
David S. Silberstein9.24%1,044,000$4.10MInsider
Biological Mimetics Inc9.24%1,044,000$4.10MInsider
Bios Capital Management LP7.65%864,435$3.40MInstitution
Arunkumar Asaithambi3.91%441,960$1.74MInsider
Vanguard Capital Management LLC2.94%332,079$1.31MInstitution
CM Management LLC2.21%250,000$982.50kInstitution
Green Park Golf Ventures II LLC1.16%131,697$517.57kInsider
Renaissance Technologies LLC1.03%116,000$455.88kInstitution

1 of 3

LTRN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LTRN18.55%60.50%Net BuyingNet Buying
GRCE26.20%43.28%
GOSS72.34%15.03%Net Buying
ESLA12.03%68.95%Net Buying
APLM0.03%52.84%Net SellingNet Selling

Lantern Pharma Stock Ownership FAQ

Who owns Lantern Pharma?

Lantern Pharma (NASDAQ: LTRN) is owned by 18.55% institutional shareholders, 60.50% Lantern Pharma insiders, and 20.95% retail investors. Leslie W. Kreis is the largest individual Lantern Pharma shareholder, owning 2.96M shares representing 26.17% of the company. Leslie W. Kreis's Lantern Pharma shares are currently valued at $10.56M.

If you're new to stock investing, here's how to buy Lantern Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.